Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2021-11-25 2021-11-18
Drug Identification Number 02240352 02240352
Brand name INTEGRILIN INTEGRILIN
Common or Proper name Eptifibatide Injection Eptifibatide Injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients EPTIFIBATIDE EPTIFIBATIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 1
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices. Other (Please describe in comments)
Anticipated start date 2021-11-26 2021-11-22
Actual start date 2021-11-24
Estimated end date 2021-12-29 2021-12-29
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments tbc
Health Canada comments